EUVIMEDEUVIMED entdecken
Open Access

A two-step mechanism for RIG-I activation by influenza virus mvRNAs

Emmanuelle Pitré iD, Karishma Bisht iD, Kaleigh A Remick, Amir Ghorbani iD, Jonathan W Yewdell iD, Elizaveta Elshina iD, Aartjan J W Te Velthuis iD

Science Advances · 08.08.2025 · 11 (32)

DOI: 10.1126/sciadv.adw8034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 08.08.2025. Verfasst von Emmanuelle Pitré und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA. Hauptthemen laut MEDLINE: RNA, Viral, DEAD Box Protein 58, Influenza A virus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza A virus (IAV) noncanonical RNAs are bound by retinoic acid–inducible gene I (RIG-I). However, innate immune activation is infrequent and it is not understood why noncanonical IAV RNAs activate RIG-I in a sequence- or RNA structure–dependent manner. We hypothesized that multiple events need to occur before IAV RNA synthesis activates RIG-I and investigated whether RIG-I activation is stimulated by the noncanonical or aberrant transcription of mini viral RNAs (mvRNA), an RNA that is overexpressed in highly pathogenic IAV infections. We find that mvRNAs can cause noncanonical transcription termination through a truncated 5′ polyadenylation signal or a 5′ transient RNA structure that interrupts polyadenylation. The resulting capped complementary RNAs stimulate the release of an mvRNA and complement RIG-I activation in trans. Overall, our findings indicate that sequential rounds of noncanonical or aberrant viral replication and transcription are needed for innate immune signaling by IAV RNA synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, ViralDEAD Box Protein 58Influenza A virusHumansReceptors, ImmunologicImmunity, InnateVirus ReplicationTranscription, GeneticAnimalsSignal TransductionInfluenza, Human

Substanzen

RNA, ViralDEAD Box Protein 58RIGI protein, humanReceptors, Immunologic

Autor:innen und Institutionen

  • Lewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
  • Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 2QQ, UK.
  • Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

ORCID-Profile: Emmanuelle Pitré, Karishma Bisht, Amir Ghorbani, Jonathan W Yewdell, Elizaveta Elshina, Aartjan J W Te Velthuis

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Pitré, E., Bisht, K., Remick, K. A., Ghorbani, A., Yewdell, J. W., Elshina, E., & Te Velthuis, A. J. W. (2025). A two-step mechanism for RIG-I activation by influenza virus mvRNAs. Science Advances, 11(32). https://doi.org/10.1126/sciadv.adw8034

Vancouver

Pitré E, Bisht K, Remick KA, Ghorbani A, Yewdell JW, Elshina E, et al. A two-step mechanism for RIG-I activation by influenza virus mvRNAs. Science Advances. 2025;11(32). doi:10.1126/sciadv.adw8034

BibTeX
@article{Pitr2025,
  author = {Pitré, Emmanuelle and Bisht, Karishma and Remick, Kaleigh A and Ghorbani, Amir and Yewdell, Jonathan W and Elshina, Elizaveta and Te Velthuis, Aartjan J W},
  title = {A two-step mechanism for RIG-I activation by influenza virus mvRNAs},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {32},
  doi = {10.1126/sciadv.adw8034}
}
Kostenlos starten →